COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
Paolo Preziosa, Maria A. Rocca, Agostino Nozzolillo, Lucia Moiola, Massimo Filippi
Topics & Concepts
CladribineMultiple sclerosisRelapsing remittingMedicineCoronavirus disease 2019 (COVID-19)NeurologyNeuroradiology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsInternal medicineVirologyImmunologyDiseaseInfectious disease (medical specialty)PsychiatryOutbreakMultiple Sclerosis Research StudiesChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia research